MKI67 and breast cancer: The latest recommendations from the International Ki-67 in Breast Cancer working group opined that Ki-67 above 30% could be considered high-risk and for patients with Ki-67 between > 5-<30% advice from a prognostic test should be considered for deciding on chemotherapy use [28].